PRKCB was reported to be hypermethylated in lung adenocarcinoma stage I while hypomethylated in stage II [18], suggesting a potential of PRKCB hypermethylation assessment for NSCLC early detection. Here, PRKCB is linked to non-small cell lung carcinoma.